CoviDx SARS-CoV-2 Rapid Antigen Test was compared to an Emergency Use Authorized molecular (RT-PCR) test for SARS-CoV-2. The samples were collected during high and low prevalence states and are inclusive of newly emerging variant strains including the UK (B.1.1.7.), South African and Denmark variants.


CoviDx SARS-CoV-2 Rapid Antigen Test results were stratified by RT-PCR cycle threshold (Ct) to show assay performance in the context of the viral load present in the clinical sample.

_{1. Lumos Diagnostics. Internal data. 2021.}